Johnson & Johnson inks $700M deal to resolve talc consumer protection claims from 42 states kdunleavy Tue, 01/23/2024 – 14:33 More: Johnson & Johnson inks 0M deal to resolve talc consumer protection claims from 42 states Source: fierce
read moreAhead of key Stelara patent cliff, J&J’s pharma business churns out growth fkansteiner Tue, 01/23/2024 – 11:32 More: Ahead of key Stelara patent cliff, J&J's pharma business churns out growth Source: fierce
read moreGenmab loses appeal in Darzalex royalties arbitration case against Johnson & Johnson kdunleavy Tue, 01/23/2024 – 10:24 More: Genmab loses appeal in Darzalex royalties arbitration case against Johnson & Johnson Source: fierce
read moreJ&J, Legend’s Carvykti bid for earlier multiple myeloma use will face FDA adcomm aliu Tue, 01/23/2024 – 10:14 More: J&J, Legend's Carvykti bid for earlier multiple myeloma use will face FDA adcomm Source: fierce
read moreFDA chides Novartis for ‘false or misleading’ Kisqali TV spot, dissecting ad claims in an untitled letter ntaylor Tue, 01/23/2024 – 08:47 More: FDA chides Novartis for ‘false or misleading’ Kisqali TV spot, dissecting ad claims in an untitled letter
read moreAutosomal dominant polycystic kidney disease affects more than 12 million people globally More: MIT researchers repurpose cancer compound to treat PKD Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals